Honeywell International enters its June 8 earnings event with fresh analyst momentum at its back — and a market that has quietly unwound most of its pre-event defensiveness since the last preview.
Goldman Sachs moved decisively this morning, raising its price target on HON to $276 from $258 while holding its Buy rating. That is the most significant single analyst action since the post-May-22 earnings rally, and it lifts Goldman's target well above the current consensus of $248. The broader Street direction has turned positive again after a cluttered April — Barclays raised its own target to $251 last week, reversing two cuts filed ahead of the prior print, while RBC Capital reiterated Outperform at $268. The consensus is not unanimous: Morgan Stanley holds an Equal-Weight at $245, and TD Cowen's Buy sits at just $230, below the current price of $235.23. Still, the weight of recent moves is upward, with the majority of target changes since mid-May pointing in the same direction as Goldman's.
Options positioning has eased substantially from where it was on June 2, when an earlier earnings preview flagged a put/call ratio at 2.6 standard deviations above its 20-day average. That elevated defensive reading has since faded — the PCR now runs at 0.38, barely below its 20-day mean of 0.39, with a z-score of just -0.47. The prior spike looks more like pre-event noise than a sustained shift in sentiment. The lending market tells the same unhurried story: short interest is 1.76% of the free float, down about 5% over the past week and down a similar amount over the month. Borrow costs are negligible at 0.39% annualised. Availability is effectively unlimited — shares available to borrow dwarf outstanding short positions by orders of magnitude. There is no squeeze pressure here, and no sign that bears are building.
The Street's bull case for Honeywell rests on aerospace and industrial automation, with recurring aftermarket services providing revenue floor. Bears flag cyclical exposure, margin pressure, and the complexity of the pending portfolio breakup — specifically the anticipated Aerospace spin-off, which Goldman's raised target implicitly endorses as a value catalyst. Valuation has re-rated over the past month: the P/E has expanded by roughly 2.2 points to 21.6x, and the P/B has moved up by 1.2 points to 8.5x. Neither multiple looks stretched for an industrial-technology conglomerate with forward EPS revisions running strongly positive — the 12-month forward EPS growth rank sits in the 70th percentile. The ORTEX short score of 31.8 is benign, drifting gently lower over the past ten sessions.
Recent earnings reactions provide useful context. The May 22 print generated a 3.5% one-day gain and a 6.3% five-day gain — a clean beat-and-hold pattern. Before that, the April 23 print produced a 3.1% one-day loss and a 2.6% five-day loss. The stock has historically moved meaningfully in both directions, making June 8 a binary read on whether the industrial cycle and Aerospace spin-off narrative are holding together. Closest peer MMM fell 0.7% on the week against HON's 1.5% gain, while SIE on the Frankfurt exchange gained 2.3% — suggesting the industrial conglomerate space broadly has some wind behind it heading into the event.
The June 8 print therefore becomes a verdict on whether Goldman's freshly raised conviction, the month-long price recovery, and the forward earnings upgrade cycle can survive contact with actual quarterly numbers — particularly on aerospace margin delivery and any update on the spin-off timeline.
See the live data behind this article on ORTEX.
Open HON on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
